Michigan's first hemp license suspension could signal a shift in regulatory oversight, suggesting state officials may be ...
Opinion
Talking With Docs on MSNOpinion
What cannabidiol oil actually is and whether you should consider using it
What cannabidiol oil actually is and whether you should consider using it ...
FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures ...
Cross-departmental body created after HSE lab uncovers high-risk synthetic cannabinoids in vapes, vape liquids and edible ...
Pharmaceutically manufactured CBD reduced patient-reported pain scores and lowered inflammatory markers in patients with ...
Talking With Docs on MSN
What physicians need patients to understand about cannabidiol products
Disclaimer. This content is for educational purposes only and is not a substitute for professional medical advice. If you are ...
FibroBiologics announces Australian patent accepted for cannabidiol adjuvant therapy for treatment of degenerative disc disease: Houston Friday, August 21, 2026, 16:00 Hrs [IST] F ...
Citi Pharma Limited is seeking shareholder approval to expand its business into cannabis, industrial hemp, and medicinal ...
PA Media on MSN
High-risk cannabinoids found in some vapes
High-risk synthetic cannabinoids have been found in products sold in shops in Ireland, according to the HSE’s early warning ...
Studies have found common challenges and misunderstandings preventing better, more goal-concordant outcomes among certain ...
A bipartisan group of lawmakers, including Rep. Dave Joyce, wants answers by Sept. 30 on how a policy shift ordered by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results